Betancourt S V, Solvay M J, Irani D N, Thomas D W, Nairn R
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor 48109.
J Immunol. 1987 Dec 1;139(11):3725-9.
The mechanism of presentation of foreign antigens to helper T lymphocytes and the nature of the structures involved in this process are not totally understood. It is well documented that this event is carried out by antigen-presenting cells (APC) (e.g., macrophages, dendritic cells, and B lymphocytes) that internalize the antigen, process it, reexpress it on their membrane surface, and present it to the T cell in the context of major histocompatibility complex class II (Ia) molecules. Recent evidence supports the hypothesis that peptide antigens associate directly with Ia molecules on the APC surface membrane. However, the characteristics of other APC membrane structures potentially involved in antigen presentation are not entirely clear. Previous studies in our laboratories identified a guinea pig macrophage membrane-bound, non-Ia-containing antigenic complex (peak A) formed upon incubation of APC with the octapeptide antigen angiotensin (AII). This complex was capable of stimulating AII-immune guinea pig T cells and thus appeared to contain the immunologically relevant form of the antigen. For this reason it was important to establish whether such complex formation with peptides occurs with other cell types and with other peptide antigens. In the present study we found that other types of cells are also capable of forming such a membrane complex with antigen (peak A) and that this event is not unique to AII. Two other peptides, alpha-melanocyte-stimulating hormone and human fibrinopeptide B, both of which are antigenic in mice, were found to form peak A with a number of murine cell lines. As in our earlier studies with guinea pig macrophages, there was no evidence from these experiments for a role for major histocompatibility complex Ia antigens in the peptide binding observed. Differences in both the amount of peak A formation and the pattern of peptide antigen degradation were found from cell line to cell line for a given peptide, and from peptide to peptide for a given cell line, suggesting cellular heterogeneity in peptide processing and retention. In addition, cross-inhibition studies indicated that there was peptide specificity in the formation of peak A perhaps suggestive of molecular heterogeneity in the structure of peak A. These results indicate that there may be several types of cell surface molecules that specifically bind and retain peptide antigens.(ABSTRACT TRUNCATED AT 400 WORDS)
将外来抗原呈递给辅助性T淋巴细胞的机制以及这一过程中所涉及结构的性质尚未完全明确。有充分证据表明,这一过程由抗原呈递细胞(APC)(如巨噬细胞、树突状细胞和B淋巴细胞)完成,这些细胞摄取抗原、对其进行处理、在细胞膜表面重新表达,并在主要组织相容性复合体II类(Ia)分子的背景下将其呈递给T细胞。最近的证据支持这样一种假说,即肽抗原直接与APC表面膜上的Ia分子结合。然而,其他可能参与抗原呈递的APC膜结构的特征尚不完全清楚。我们实验室之前的研究发现,将APC与八肽抗原血管紧张素(AII)孵育后,会形成一种豚鼠巨噬细胞膜结合的、不含Ia的抗原复合物(峰A)。这种复合物能够刺激AII免疫的豚鼠T细胞,因此似乎包含抗原的免疫相关形式。出于这个原因,确定这种与肽的复合物形成是否也发生在其他细胞类型和其他肽抗原上很重要。在本研究中,我们发现其他类型的细胞也能够与抗原形成这种膜复合物(峰A),而且这一现象并非AII所特有。另外两种肽,α-黑素细胞刺激素和人纤维蛋白肽B,在小鼠体内均具有抗原性,我们发现它们与多种小鼠细胞系形成了峰A。正如我们早期对豚鼠巨噬细胞的研究一样,这些实验没有证据表明主要组织相容性复合体Ia抗原在观察到的肽结合中起作用。对于给定的肽,不同细胞系之间峰A形成的量以及肽抗原降解模式存在差异;对于给定的细胞系,不同肽之间也存在差异,这表明在肽的处理和保留方面存在细胞异质性。此外,交叉抑制研究表明,峰A的形成存在肽特异性,这可能暗示峰A结构存在分子异质性。这些结果表明,可能存在几种特异性结合并保留肽抗原的细胞表面分子。(摘要截选至400字)